Alberto Espay studied deaths linked to new Alzheimer’s drugs Aduhelm and Leqembi. His findings showed higher death risks, which caused strong backlash and threats. The situation reveals how drugmakers influence the FDA and silence critics.
ORIGINAL LINK: https://www.levernews.com/science-for-sale-how-drugmakers-captured-the-fda/